Can reduced folic acid and vitamin B12 levels cause deficient DNA methylation producing mutations which initiate atherosclerosis?

Medical Hypotheses

Volumn 53, Issue 5, 1999, Pages 421-424

  Newman, P E ^a  

^a NONE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; CHOLESTEROL; CYANOCOBALAMIN; DNA; FOLIC ACID; HOMOCYSTEINE; PYRIDOXINE; S ADENOSYLMETHIONINE;

AMINO ACID BLOOD LEVEL; ATHEROMA; ATHEROSCLEROSIS; CELL PROLIFERATION; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CYANOCOBALAMIN DEFICIENCY; DNA METHYLATION; DRUG MEGADOSE; FOLIC ACID DEFICIENCY; GENE MUTATION; HUMAN; HYPOTHESIS; INTIMA; ISCHEMIC HEART DISEASE; PRIORITY JOURNAL; PYRIDOXINE DEFICIENCY; SHORT SURVEY; SMOOTH MUSCLE FIBER; VITAMIN BLOOD LEVEL;

EID: 0032744380     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1054/mehy.1998.0794     Document Type: Article

References (12)

1. Steinberg D. The Cholesterol Controversy is over. Why did it take so long. Circulation. 80:1989;1070-1077.
2. Stamler J., Wentworth D., Neaton J. D. Is relationship between serum cholesterol and risk of premature death from Coronary heart disease continuous and graded. J Am Med Assoc. 256:1986;2823-2827.
3. Ravnskof U. Cholesterol lowering trials in cornary heart diseases: frequency of citation and outcome. Br Med J. 305:1992;15-19.
4. Strandberg T. E., Salomaa V. V., Veikko V. Long term mortality after 5-year multifactorial primary prevention of cardiovascular diseases in middle-aged men. J Am Med Assoc. 266:1991;1225-1229.
5. Horrobin D. F. Letter to the Editor. Br Med J. 301:1990;554.
6. Ubbink J. B., Haywood Vermask W. J., van her Merwe A. Vitamin B-12, vitamin B-6, and folate nutritional status in men with hyperhomocysleinomia. Am J Clin Nutr. 57:1993;47-53.
7. Verhoef P., Kok F. J., Dick A. C. M. Plasma total homocysteine, B vitamins and risk of cornary atherosclerosis. Arter Thromb Vas Biol. 17:1997;989-995.
8. Stampfer M. J., Malinow R. M. Can lowering homocysteine levels reduce cardiovascular risk. N Eng J Med. 332:1995;328-329.
9. Graham J. M., Daly L. E., Refsum J. M. Homocysteine as a risk factor for vascular disease. J Am Med Assoc. 227:1997;1775-1781.
10. Mason J. B., Levesque T. Folate: effects on carcinogenesis and the potential for cancer chemoprevention. Oncology. 10:1996;1727-2742.
11. Kunz J. The American Medical Association Family Medical Guide. 1982;Random House, New York. p. 373.
12. Cravo M., Fidalgo P., Pereira A. DNA methylation as an intermediate biomarker in colorectal cancer: modulation by folic acid supplementation. Eur J Cancer Prevent. 3:1994;473-479.